A $20 million grant from the Saverin Foundation is set to supercharge metastatic breast cancer research at Dana-Farber Cancer Institute. This isn’t just another donation—it’s the largest non-federal grant of its kind at Dana-Farber, and it’s all about accelerating breakthroughs. The funds will help harness AI to personalize treatments, expand clinical trials, and dig deeper into why some therapies work while others don’t. For Boston families and anyone touched by cancer, this could mean faster progress and more hope. What do you think—will this kind of investment change the game for cancer care? #Safety #Boston #CancerResearch